Pythons do something that seems almost impossible from a human perspective. They can swallow a massive meal and then go months without eating, sometimes even longer, while staying metabolically healthy and maintaining their muscle mass.
A new study suggests part of that trick may come from a compound in python blood that powerfully suppresses appetite.
Researchers at the University of Colorado Boulder (UC Boulder), working with other universities, report that they’ve identified a molecule that spikes in python blood after a meal. In mice, the molecule triggers weight loss by acting on the brain’s appetite center.
The striking part is that the mice didn’t experience the usual nausea, gastrointestinal problems, energy crashes, or muscle loss that can come with many current weight-loss drugs.
“This is a perfect example of nature-inspired biology,” said senior author Leslie Leinwand, a professor at CU Boulder who has studied pythons for decades.
The python lifestyle is basically feast-or-famine taken to an extreme. Some species can grow enormous, swallow prey whole, and then go into a long stretch of no eating at all, without the kind of metabolic damage you’d expect in many animals.
Leinwand’s previous work has shown that, in the hours after a python eats, its metabolism can accelerate dramatically, and its heart can expand by about 25 percent to support digestion.
That “digestive reboot” is one reason pythons have become such a compelling model for researchers interested in metabolism, muscle maintenance, and organ adaptation.
For the new study, Leinwand teamed up with Jonathan Long, a Stanford pathology professor who studies metabolites – small molecules in the blood that reflect how the body produces and uses energy.
“If we truly want to understand metabolism, we need to go beyond looking at mice and people and look at the greatest metabolic extremes nature has to offer,” Long said.
Because researchers build most biomedical research around rodents and humans, they can easily overlook weird but useful chemistry unique to other animals.
Blood chemistry shifts after feeding
The team collected blood samples from ball pythons and Burmese pythons that were fed on a schedule – once every 28 days – and drew blood immediately after the snakes ate.
They identified 208 metabolites that rose significantly following feeding. One compound stood out dramatically: para-tyramine-O-sulfate (pTOS), which surged by about 1,000-fold.
That kind of spike is hard to ignore. It is the biological equivalent of a flare gun going off, signaling that this molecule matters in that moment.
Appetite effects tested in mice
To see whether pTOS has a meaningful effect on appetite and weight, the researchers administered high doses of the compound to both heavy weight and lean mice.
The results were encouraging. The python blood compound acted on the hypothalamus – the brain region heavily involved in appetite regulation – and promoted weight loss.
Even more notable, the mice did not show the problems that often limit weight-loss drugs in real-world use – no obvious gastrointestinal distress, no loss of energy, and no muscle loss.
That last point is especially important. Many people turn to appetite-suppressing medications because they are effective. However, some stop taking them due to side effects, while others lose more lean mass than they would like.
“We’ve basically discovered an appetite suppressant that works in mice without some of the side-effects that GLP-1 drugs have,” said Leinwand, referencing medications like Ozempic and Wegovy.
A microbe-made molecule
Another twist: pTOS appears to be produced by the python’s gut bacteria. It’s not something mice naturally have in their system, which helps explain why it’s been missed.
If you build your whole research ecosystem around mice and rats, you’re unlikely to stumble onto a compound that isn’t part of their normal biology.
Researchers see pTOS at low levels in human urine and note that it rises after a meal, but it has not caught much attention in rodent-focused research.
Reptiles have inspired drugs before
Leinwand also points out that the current wave of GLP-1 drugs has a reptilian origin story of its own.
Gila monster venom contains a hormone-like compound that helped inspire drugs targeting GLP-1 pathways.
Millions of people now use those medications, but there is still room for improvement. Some studies suggest that up to half of users stop taking GLP-1 drugs within a year, often because of side effects or tolerability.
“We believe there is still room for therapeutic growth in this market,” Leinwand said.
To move in that direction, Leinwand, Long, and colleagues have formed a startup, Arkana Therapeutics, aimed at translating “python lessons” into potential therapies.
Their long-term vision includes chemically synthesizing analogs of rare python metabolites and developing them into drugs.
Fighting muscle loss with python blood
The researchers aren’t framing this as a one-trick discovery. Pythons maintain muscle exceptionally well during long fasting periods, raising another major medical question: could python biology help with sarcopenia, the age-related loss of muscle mass that eventually affects most people?
Right now, there is no widely effective therapy that can stop or reverse sarcopenia. If pythons can preserve muscle through long periods without food or exercise, there may be biochemical pathways worth studying.
Leinwand said the team wants to go further than pTOS alone. Some of the other metabolites they identified increased by 500 to 800 percent after feeding, and they may also have useful physiological effects.
“We’re not stopping with just this one metabolite,” Leinwand said. “There’s a lot more to be learned.”
Weight-loss drugs from python blood
This study doesn’t mean “python blood is the next Ozempic.” But it does highlight something important: animals with extreme lifestyles may carry biochemical tools that modern medicine hasn’t yet recognized.
pTOS is a molecule that spikes in python blood after feeding. In mice, it appears to reduce appetite by acting on the brain while avoiding some of the major side effects that make existing drugs difficult for some people to tolerate.
Researchers now need to determine whether it works safely in humans and how they can optimize it. The team also wants to know what other “hidden” metabolites in python blood produce that could help with weight loss, metabolic health, or even muscle preservation.
At the very least, it’s a reminder that the natural world is full of unusual solutions – and sometimes the best way to find a new drug idea is to study an animal doing something humans can’t.
The study is published in the journal Nature Metabolism.
—–
Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates.
Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.
—–